This review explores the multifaceted role of the canonical NF-κB signaling pathway in the context of obesity-induced inflammation, with particular emphasis on the molecular architecture, key regulatory components, clinically relevant biomarkers and potential therapeutic strategies. Here, NFKB1 is linked to obesity disorder.